Logo 871 (Glipizide extended release 2.5 mg)

Pill imprint Logo 871 has been identified as Glipizide extended release 2.5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for Logo 871 (Glipizide extended release 2.5 mg)

Glipizide extended release 2.5 mg Logo 871  Front
Glipizide extended release 2.5 mg Logo 871  Back
Glipizide extended release
Imprint:
Logo 871
Strength:
2.5 mg
Color:
Blue
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Andrx Pharmaceuticals
National Drug Code (NDC):
62037-0871

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)